Mark E. Davis

Mark E. Davis is the Warren and Katherine Schlinger Professor of Chemical Engineering at the California Institute of Technology. He is a member of the City of Hope National Medical Center. He earned his B.S., M.S., and Ph.D. in chemical engineering all from the University of Kentucky. His lab focuses on the synthesis of materials for catalysis and biocompatible materials for drug delivery.

Davis was elected as a member into the National Academy of Engineering in 1997, for pioneering work in the synthesis of new catalytic materials.

Research He did his doctoral work with John Yamanis on reactions engineering with annular bed reactors. His academic career started as an assistant professor at Virginia Polytechnic Institute & State University in 1981 and rose until becoming the Charles O. Gordon Professor of Chemical engineering in 1990. During his time at Virginia Tech, he developed some of the earlier Zeolite molecular sieves and increasing the pore size. In 1991, he joined the faculty of the California Institute of Technology and served as the Executive Officer of the department from 1999 to 2004. In 2004 he joined the City of Hope National Medical Center, Comprehensive Cancer Center. The compound, CRLX101 is now being tested in clinical trials. He is also the founder of Insert Therapeutics and Calando Pharmaceuticals.

Personal Mark was born in Ellwood City, Pennsylvania, as the son of teachers of history and English. He met his wife Mary while a professor at Virginia Tech. She was an accomplished flautist before being diagnosed with breast cancer.